1,3,6-Trimethyl-1 H -pyrazolo[3,4- b ]pyridine-4-carboxylic acid, 95.0%, 1g

Oxazole, 2-[2-(diphenylphosphino)phenyl]-4,5-dihydro-4-(1-methylethyl)-, (4S)-, 98%, 5g

3-Oxo-3H-benzo[f]chromene-2-carboxylic acid, 95+%, 1g

1,4-Bis(bromomethyl)-2,3,5,6-tetramethylbenzene, 95.0%, 5g

[4-(3-Chloro-5-trifluoromethyl-pyridin-2-yl)-pyrimidin-2-ylsulfanyl]-acetic acid, 95.0%, 100mg

Rel-(1r,4r)-4-(4-(4-fluorophenyl)-5-(2-methoxypyrimidin-4-yl)-1H-imidazol-1-yl)cyclohexan-1-ol, 99+%, 5mg

2-(2-Aminoacetamido)acetic acid hydrochloride, 98%, 5g

Ethyl 3-((S)-1-((1S,3aS,7aS,E)-4-((Z)-2-((3S,5R)-3,5-bis((tert-butyldimethylsilyl)oxy)-2-methylenecyclohexylidene)ethylidene)-7a-methyloctahydro-1H-inden-1-yl)ethoxy)propanoate, 97%, 25mg

3-(2-Pyridyl)-5,6-diphenyl-1,2,4-triazine, 98.0%, 1g

(R)-2-Amino-6-((tert-butoxycarbonyl)amino)hexanoic acid, 95.0%, 25g

3-(2-(2-(2-Methoxyethoxy)ethoxy)ethoxy)thiophene, 97.0%, 1g

4-(O-tolyl)butanoic acid, 98+%, 250mg

1-(Piperidin-4-yl)azetidin-3-ol, 95.0%, 100mg